Search
P3 Health Partners Inc
PIIIAdd to Watchlist
5.630USD
+0.010+0.18%
Close 10-07 16:00（ET）
40.76MMarket Cap
0.02P/E TTM
P3 Health Partners Inc (PIII) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to P3 Health Partners Inc in the past month.
Buy
0 Strong Buy
1 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
18.000USD+183.02%
PIII Analyst Recommendation Trends
In the current month, PIII has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. PIII average Analyst price target in the last month is 18.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
1
1
1
1
1
1
2
2
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
3
3
PIII Analyst Rating for Peer Comparison
Updated: Oct 6, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
IQVIA Holdings Inc
IQV
7
12
6
0
0
25
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Biontech SE
BNTX
4
12
6
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, PIII EPS is projected to reach -3.965 in FY2026Q3, following reported EPS of -0.632 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-9.46
-3.50
-1.90
-3.96
-5.62
Actual
-23.02
0.37
-0.63
--
--
Surprise
-143.18%
+110.61%
+66.63%
--
--
FAQs
What is P3 Health Partners Inc's expected revenue for the next quarter?
P3 Health Partners Inc's expected revenue is 384.80M.
What is P3 Health Partners Inc's price target?
Analysts forecast that P3 Health Partners Inc's price target is USD 18.00, with the highest forecast at USD 23.00 and the lowest forecast at USD 13.00.
How have P3 Health Partners IncPIII's recent earnings per share performed?
The market expectation was USD -0.63, while P3 Health Partners IncPIII's earnings per share (EPS) for the previous quarter was USD 0.37. EPS for the next quarter is expected at USD -3.96.
What is the analyst rating for P3 Health Partners Inc?
Based on the ratings of P3 Health Partners Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.